Thomas J. Schall - 01 Dec 2021 Form 4 Insider Report for ChemoCentryx, Inc.

Role: President and CEO, Director
Signature: /s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Dec 2021
Net transactions value: +$499,994
Form type: 4
Filing time: 03 Dec 2021, 18:39:41 UTC
Next filing: 04 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCXI	Common Stock	Options Exercise	$399,996	+38,948	+1.7%	$10.27	2,347,828	01 Dec 2021	Direct
transaction	CCXI	Common Stock	Options Exercise	$99,998	+6,988	+0.3%	$14.31	2,354,816	01 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CCXI	Stock Option (right to buy)	Options Exercise		-38,948	-100%		0	01 Dec 2021	Common Stock	38,948	$10.27	Direct	F1, F2
transaction	CCXI	Stock Option (right to buy)	Options Exercise		-6,988	-100%		0	01 Dec 2021	Common Stock	6,988	$14.31	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	As of December 1, 2021, and prior to this transaction, the exercised options were fully vested.
F2	Not applicable.